Food Or Edible As Carrier For Pharmaceutical Patents (Class 424/439)
  • Patent number: 9693972
    Abstract: Described herein are methods, compositions, systems, and kits that effectively deliver a laxative to a patient along with effective electrolyte replenishment by delivering both a laxative and electrolytes via a food item. The food item is prepared by either combining, mixing, or integrating the ingredients that form the food item together with one of or both of a laxative and electrolytes so that the ingredients in the food item either eliminate or significantly reduce the poor taste associated with either the electrolytes or the laxative. Eliminating or reducing the poor taste associated with either electrolytes or laxative, greatly improves patient satisfaction and compliance with ingesting these substances in order to, for example, prepare the GI tract of the patient for a medical or surgical procedure.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: July 4, 2017
    Assignee: COLONARYCONCEPTS LLC
    Inventors: Michael Allio, Jonathan Gordon
  • Patent number: 9675097
    Abstract: Disclosed herein are shelf-stable, clear liquid nutritional compositions having a pH ranging from 2.5 to 4.6 and comprising water; at least one source of EGCg in an amount sufficient to provide 200-1700 mg/L of EGCg; and at least one source of protein in an amount sufficient to provide 25-45 g/L of total protein. The shelf-stable, clear liquid nutritional compositions lose no more than 20% by weight solids of the EGCg content present in the initial formulation of the compositions to epimerization, degradation, or both epimerization and degradation during heat sterilization. In certain embodiments, the loss of EGCg is exhibited by the amount of epimerization product GCg present in the shelf-stable, clear liquid nutritional composition following heat sterilization. Methods for preparing the shelf-stable, clear liquid nutritional compositions are also disclosed herein.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: June 13, 2017
    Assignee: ABBOTT LABORATORIES
    Inventors: Gaurav Patel, Paul Johns, Normanella Dewille, Suzette Pereira
  • Patent number: 9649347
    Abstract: An anti-oxidative Lactobacillus rhamnosus CCFM1107 can relieve chronic alcoholic liver injury, and L. rhamnosus CCFM1107 can be used in preparing dairy products as starter culture. The dairy products of this invention include milk, milk powder, milk capsules or fermented milk containing L. rhamnosus CCFM1107. It has strong abilities of anti-oxidation, scavenging diphenyl picrylhydrazyl (DPPH) radical and hydroxyl radical, inhibiting lipid peroxidation, tolerating cholate, chlorine sodium and pH, and can improve liver function and antioxidative index, lower serum endotoxin level and regulate intestinal flora distribution, thus effectively relieving alcoholic liver injury of mice.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: May 16, 2017
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Wei Chen, Fengwei Tian, Wenli Huang, Jianxin Zhao, Hao Zhang, Gang Wang, Qiuxiang Zhang, Xiaoming Liu, Daming Fan, Feifei Chi
  • Patent number: 9649322
    Abstract: A solid supplement comprising the following components (A) and (B): (A) sphingomyelin in an amount of from 0.15 to 7% by mass; and (B) phosphatidyl inositol or a salt thereof, wherein the mass ratio of the content of phosphatidyl inositol or the salt thereof (B) in terms of phosphatidyl inositol content to the content of sphingomyelin (A) in the solid supplement, i.e., [(B)/(A)], is from 0.05 to 3.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: May 16, 2017
    Assignee: KAO CORPORATION
    Inventors: Youichi Arai, Yuki Ishida, Yasushi Shioya
  • Patent number: 9643147
    Abstract: This invention relates to compositions that have utility, amongst others, in the stabilization of suspension particles or gas bubbles in fluid water-based compositions and/or in conferring shear thinning behavior to such fluid water-based compositions. The inventors have developed parenchymal cellulose based materials, which comprise cell wall derived networks of cellulose based fibers and nanofibrils, can advantageously be used for stabilization of suspended solid particles in fluid water-based compositions. Specific aspects of the invention concern the parenchymal cellulose based materials, their production and their use in fluid water-based compositions, as well as the resulting fluid water-based compositions per se.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: May 9, 2017
    Assignee: KONINKLIJKE COÖPERATIE COSUN U.A.
    Inventors: Gerardus Petrus Franciscus Maria van Engelen, Gijsbert Adriaan van Ingen, Corne Meeuwissen, Robert Nolles
  • Patent number: 9610282
    Abstract: The present disclosure relates to compositions and methods that are effective in controlling and preventing bacterial, viral and fungal infections in the living tissue of plants, humans and animals, and in advancing the healing process for wounds to that tissue. The disclosed compositions comprise a biocidal system, a pH buffer, and one or more of a surfactant, a cellular energy supplement, an inflammation reducer, a clotting agent, an electrolytic system, a lattice forming system, and for plants a fungicide, all in an aqueous composition.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: April 4, 2017
    Assignee: NBIP, LLC
    Inventors: John W. Veenstra, Burt R. Sookram
  • Patent number: 9597296
    Abstract: This invention relates to use of glycerol-containing solutions for improving both the metabolic and hydration state of fasting individuals. The same solutions can be utilized in persons facing situations where urination is impossible or inconvenient.
    Type: Grant
    Filed: January 16, 2009
    Date of Patent: March 21, 2017
    Inventor: Stephan Lück
  • Patent number: 9597367
    Abstract: The present invention encompasses combinations comprising a plurality of amino acids, formulations thereof for use in humans and animals, as well as methods for increasing muscle protein synthesis, muscle strength, and/or muscle function in a subject with chronic heart failure, cardiac cachexia or a combination thereof.
    Type: Grant
    Filed: April 18, 2014
    Date of Patent: March 21, 2017
    Assignee: BIOVENTURES, LLC
    Inventors: Robert R. Wolfe, Jeanne Wei
  • Patent number: 9592197
    Abstract: A pharmaceutical dosage form which comprises diphenhydramine and/or a pharmaceutically acceptable salt thereof and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with a substantial part of the period over which the dosage form provides a plasma concentration within the therapeutic range of diphenhydramine or salt thereof. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: March 14, 2017
    Assignee: SOVEREIGN PHARMACEUTICALS, LLC
    Inventors: Viswanathan Srinivasan, Juan Carlos Menendez, Venkatesh Balasubramanian, Somphet Peter Suphasawud, Ralph Brown, David Brown
  • Patent number: 9585966
    Abstract: The invention described herein provides a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates with a specific content and specific conjugation patterns of LA, linolenic acid (alpha-linolenic acid, gamma-linolenic acid) DHA and EPA which depend on utilizing different sources of lipids, and uses of such preparations.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: March 7, 2017
    Assignee: ENZYMOTEC LTD.
    Inventors: Gai Ben Dror, Dorit Platt, Orly Farkash, Rassan Zuabi, Zohar Bar-On, Avidor Shulman, Dori Pelled, Yael Richter
  • Patent number: 9585896
    Abstract: The present disclosure relates to pharmaceutical compositions comprising omega-3 fatty acids and vitamin D for use in at least one of preventing and treating psoriasis, and to food supplement, dietary supplement, nutritional supplement, over-the-counter (OTC) supplement, medical food, or pharmaceutical grade supplement compositions comprising omega-3 fatty acids and vitamin D for use in improving at least one parameter associated with psoriasis.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: March 7, 2017
    Assignee: PRONOVA BIOPHARMA NORGE AS
    Inventors: David A Fraser, Alexis Garras
  • Patent number: 9561283
    Abstract: The invention described herein provides a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates with a specific content and specific conjugation patterns of LA, linolenic acid (alpha-linolenic acid, gamma-linolenic acid) DHA and EPA which depend on utilizing different sources of lipids, and uses of such preparations.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: February 7, 2017
    Assignee: ENZYMOTEC LTD.
    Inventors: Gai Ben Dror, Dorit Platt, Orly Farkash, Rassan Zuabi, Zohar Bar-On, Avidor Shulman, Dori Pelled, Yael Richter
  • Patent number: 9549982
    Abstract: The present technology relates to a dietary supplement, composition, nutraceutical, and/or system for inducing or treating biological responses or conditions (namely sleep or sleep disorders) which utilize ultra-low dosage amounts of vitamins, minerals, amino acids, co-enzymes, stimulants, and/or similar ingredients in a highly bio-active delivery system which bypasses first pass metabolism. In particular, the present technology relates to a nutraceutical composition/formulation which substantially bypasses first pass metabolism and such as, but not limited to, sleep apnea. Methods of using the composition/formulation to elicit enhanced sleep quality, induce short duration sleep and/or treat sleep disorders are also provided.
    Type: Grant
    Filed: November 18, 2010
    Date of Patent: January 24, 2017
    Assignee: Foundational Biosystems, LLC
    Inventors: Ricky Dean Moneymaker, Larry S. Klesman, Jon S. Theus
  • Patent number: 9549955
    Abstract: The present invention provides for microbial compositions and methods for reducing the concentration of short-chain fatty acids in the gut as a way to reduce energy uptake and manage obesity. More specifically, the invention provides for decreasing short-chain fatty acids available for absorption in the human gut, such as acetate, using one or more of: a probiotic including a homo-acetogenic, acetate oxidizing bacterium that converts acetate to H2; a probiotic including an acetoclastic methanogen; a microbial electrolysis cell comprising a homo-acetogenic bacterium and/or an acetoclastic methanogen; a prebiotic that enhances the growth or function of acetate-scavenging microbiota; or a highly selective antibiotic that targets H2-oxidizing methanogens.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: January 24, 2017
    Assignee: Arizona Board of Regents for and on behalf of Arizona State University
    Inventors: Bruce Edward Rittmann, Rosa Krajmalnik-Brown, Husen Zhang, John Dibaise, Michael Crowell
  • Patent number: 9504750
    Abstract: Dry stabilizing compositions for bioactive materials include sugars and hydrolyzed proteins, and may be formed into tablets or other forms providing enhanced stability for the bioactive material. Compositions containing the bioactive materials may be produced by a method that includes (a) combining the bioactive material with other ingredients in an aqueous solvent to form a viscous slurry; (b) snap-freezing the slurry in liquid nitrogen to form solid frozen particles, beads, droplets or strings; (c) primary drying by water removal under vacuum of the product of step (b) while maintaining it at a temperature above its freezing temperature; and (d) secondary drying of the product of step (c) at maximum vacuum and a temperature of 20° C. or higher for a time sufficient to reduce the water activity to below 0.3 Aw.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: November 29, 2016
    Assignee: ADVANCED BIONUTRITION CORPORATION
    Inventors: Moti Harel, Qiong Tang, Trisha Rice, Kimberly Jennings, Brian Carpenter, Roger Drewes, Elizabeth Raditsis, January Scarbrough
  • Patent number: 9492421
    Abstract: The present invention relates to nutritional supplements to be administered to, or to be taken by, people who are subject, or thought to be subject to, iron deficiency anemia. The nutritional supplements of this invention have a unique formulation of iron and folic acid-related materials in addition to certain other vitamins and minerals and a nutritionally acceptable carrier therefor. The invention describes specific nutritional supplements for the use set forth above.
    Type: Grant
    Filed: October 16, 2014
    Date of Patent: November 15, 2016
    Assignee: Argent Development Group, LLC
    Inventors: Kenneth R. Greathouse, Rhett Sean Daniels
  • Patent number: 9491961
    Abstract: A method of preparing a salt product comprises the steps of: (i) providing a mixture which comprises salt dissolved in a solvent, said mixture further containing an organic material that is solid under ambient temperature conditions; and (ii) atomizing said mixture and evaporating said solvent to produce a salt product comprised of particles of salt incorporating said organic material. The organic material may be a polymer such as a carbohydrate (e.g. maltodextrin or Gum Arabic). Novel salt products are disclosed which comprise hollow particles having a shell formed for individual crystallites of salt. The salt product is useful as a seasoning for food and may be used in lower amounts than conventional salt to provide the same taste. Particular advantages are obtained in the baking of bread.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: November 15, 2016
    Assignee: EMINATE LIMITED
    Inventors: Stephen John Minter, Sarah Maude
  • Patent number: 9463224
    Abstract: Methods and compositions are provided for increasing responsiveness to therapeutic metalloproteases including increasing and/or maximizing responsiveness and preventing botulinum and tetanus toxin resistance due to a functional deficiency of zinc. Also provided are methods for zinc replacement or supplement in lacking individuals comprising the administration of a zinc supplement for a loading period and/or administration of a phytase supplement together with the zinc supplement. Also provided are methods for standardization of botulinum toxin potency assays that provide for greater certainty and margins of safety in the use of products from different manufacturers.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: October 11, 2016
    Assignee: CNSS IP Holdings, Inc.
    Inventor: Charles N. S. Soparkar
  • Patent number: 9456630
    Abstract: The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of bifidobacterium longum ATCC BAAA-999.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: October 4, 2016
    Assignee: Nestec S.A.
    Inventors: Annick Mercenier, Stephanie Blum-Sperisen, Florence Rochat
  • Patent number: 9452190
    Abstract: Methods for the treatment and prevention of neural cell and neuro-pathological disorders are provided, comprising contacting the neural cells, or administering to a subject in need thereof, botanical raw material (BRM) or an extract obtainable from passion fruits. Compositions, as well as a nutraceutical composition comprising the same are also provided.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: September 27, 2016
    Assignees: THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANISATION (ARO) (VOLCANI CENTER), YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventors: Alon Samach, Oren Tirosh, Edna Pesis, Avital Artan, Livnat Goldenberg, Aron Troen
  • Patent number: 9445621
    Abstract: The present invention relates to (fruit) juices and nectars formulations, comprising (LC)-PUFA's, which do not have the characteristic fish taste of the (long chain) polyunsaturated fatty acids. Furthermore, the present invention also relates to a base material, which comprises PUFA and ?-carotene and the use of such a base material to produce a (fruit) juice or (fruit) nectar formulation.
    Type: Grant
    Filed: September 3, 2010
    Date of Patent: September 20, 2016
    Assignee: DSM IP ASSETS B.V.
    Inventors: Simone Koenig-Grillo, Neil MacFarlane, Thomas Lindemann, Karl Manfred Voelker
  • Patent number: 9446086
    Abstract: A novel herbal extract, MF101, is effective in the treatment of symptoms of menopause.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: September 20, 2016
    Assignee: BIONOVO, INC.
    Inventor: Isaac Cohen
  • Patent number: 9433235
    Abstract: Described is a solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides in aqueous liquids, wherein the solubilization agent consists of a mixture of: (a) one emulsifying polymer or a mixture of two, three or more emulsifying polymers, (b) one saponin or a mixture of two, three or more saponins, (c) one partially or fully water-miscible, preferably liquid, solvent or a mixture of partially or fully water-miscible, preferably liquid, solvents, preferably selected from the group consisting of ethanol, propylene glycol (1,2-propanediol), glycerin, triacetin (glycerin triacetate), diacetin (glycerin diacetate) and triethyl citrate, and (d) water. The solubilization agent is particularly suitable for sparingly water soluble polyphenols, flavonoids and/or diterpenoid glucosides. The invention also relates to compositions and (food or cosmetic) formulations comprising said solubilization agent.
    Type: Grant
    Filed: January 24, 2011
    Date of Patent: September 6, 2016
    Assignee: SYMRISE AG
    Inventors: Dirk Schrader, Thomas Riess, Cornelia Homner, Christopher Sabater-Lüntzel
  • Patent number: 9431283
    Abstract: A system and method manipulate micro objects. A field generator is configured to generate a force field varying in both space and time to manipulate the micro objects on a substrate. The substrate is not permanently affixed to the field generator and allows the force field to pass through the substrate.
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: August 30, 2016
    Assignee: Palo Alto Research Center Incorporated
    Inventors: Jason Thompson, Eugene M. Chow, JengPing Lu, Gregory L. Whiting, David K. Biegelsen, Janos Veres
  • Patent number: 9416160
    Abstract: A bacterial macromolecular complex produced by bacteria belonging to the Bifidobacterium longum strain deposited according to the treaty of Budapest under number CNCM I-3994 with the Collection Nationale de Cultures de Microorganismes (CNCM) [National Collection of Microorganism Cultures], consisting of chains combining a lipoprotein and an oligosaccharide, wherein: the lipoprotein has a molecular weight of from 30 kDa to 60 kDa; the oligosaccharide has a molecular weight of less than 15 kDa, and preferably less than 10 kDa; the lipoprotein component, which consists of all the lipoproteins of each of the chains, represents from 75 to 99%, preferentially from 80 to 98%, more preferentially from 85 to 95% by weight of the total weight of the complex, and the oligosaccharide component, which consists of all the oligosaccharides combined with each of the chains, represents from 1 to 25%.
    Type: Grant
    Filed: July 5, 2011
    Date of Patent: August 16, 2016
    Assignee: BIFINOVE
    Inventors: Jean-Pierre Blareau, Michel Colavizza, Frederic Huguet, Charles Romond
  • Patent number: 9386790
    Abstract: A method of alleviating symptoms of, or treating, pancreatic beta-cell damage in a subject includes a step of identifying a subject having pancreatic beta-cell damage. Multiple cycles of a diet protocol are administered to the subject. The diet protocol includes administering of a fasting mimicking diet and a re-feeding diet where the fasting mimicking diet is provided for a first time period and the re-feeding diet is provided for a second time period.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: July 12, 2016
    Assignee: University of Southern California
    Inventors: Valter D. Longo, Chia-Wei Cheng
  • Patent number: 9375461
    Abstract: The present invention relates to a composition comprising a combination of at least one proteolytic enzyme, such as subtilisin, and at least one lipolytic enzyme, for use in preventing triglyceride synthesis, advantageously by degrading 2-monoacylglycerol in the intestine. The invention also has as an object such a composition for use as a drug, cosmetic agent, medical device, dietary composition, dietary supplement or nutraceutical, notably for use in preventing or treating obesity, atherosclerosis, type 2 diabetes or for use in preventing or reducing excess weight.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: June 28, 2016
    Assignee: IMARKO RESEARCH S.A.
    Inventor: Max Rombi
  • Patent number: 9359426
    Abstract: The present invention relates to methods for producing low-iron Lf having improved antimicrobial activity and to a low-iron Lf having improved antimicrobial activity.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: June 7, 2016
    Assignee: WESTLAND CO-OPERATIVE DIARY COMPANY LIMITED
    Inventors: Kevin Neil Pearce, Shaojiang Chen
  • Patent number: 9326539
    Abstract: This invention relates to fat containing consumable food products comprising ?-cyclodextrin. The food products have reduced levels of bioavailable fat but have substantially the same fat, cholesterol and caloric content as a like food without ?-cyclodextrin. The invention also relates to methods for reducing the bioavailability of fats in fat containing food products without reducing caloric intake as determined by bomb calorimetry and to methods for increasing high density lipoproteins in a subject and reducing or controlling weight by administering the food products of this invention.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: May 3, 2016
    Assignee: Soho Flordis International Pty Ltd.
    Inventors: Joseph D Artiss, Catherine Jen
  • Patent number: 9308223
    Abstract: A composition comprising various vitamins to make a multi-vitamin. The vitamins identified in multi-vitamin include vitamin B-1, vitamin B-2, niacinamide, vitamin B-6, vitamin B-12, pantothenic acid, folic acid, beta carotene, iron, biotin, choline, vitamin A, vitamin E and vitamin C. The multi-vitamin soothe pain, depression, weakness and insomnia and works best with variety of food and less dairy products. Lead combined with calcium effects are severe than lead effects only; it elevates blood pressure, cholesterol, glucose, weight and cause frequent infections; bigger than normal dose of antibiotics need in infections; and variation in quantities of vitamins are needed to soothe the symptoms.
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: April 12, 2016
    Inventor: Renuka Maewal
  • Patent number: 9295656
    Abstract: The present invention provides a particulate composition wherein an oil component containing reduced coenzyme Q10 is polydispersed forming a domain in a matrix containing a water-soluble excipient, which simultaneously shows high oxidative stability and high oral absorbability, a production method thereof, and a stabilizing method thereof. It also provides a food, food with nutrient function claims, food for specified health uses, dietary supplement, nutritional product, animal drug, drink, feed, pet food, cosmetic, pharmaceutical product, therapeutic drug, prophylactic drug and the like, which contain the composition.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: March 29, 2016
    Assignee: KANEKA CORPORATION
    Inventors: Takashi Ueda, Shinsuke Akao, Shiro Kitamura, Hideyuki Kishida, Takahiro Ueda
  • Patent number: 9295662
    Abstract: The present disclosure is directed to methods for enhancing, improving or increasing fertility or reproductive function. For example, the present disclosure is directed to a method for enhancing, improving, or increasing a female human's likelihood of becoming pregnant comprising: administering to the human a nutritional, dietary, or food fatty acid supplement comprising: at least 30% docosahexaenoic acid (DHA), by weight of the total fatty acids in the supplement in a form chosen from ethyl ester, free fatty acid, and triglyceride.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: March 29, 2016
    Assignees: Children's Medical Center Corporation, The General Hospital Corporation
    Inventors: Mark Puder, Deepika Nehra, Bo R. Rueda
  • Patent number: 9277763
    Abstract: Several embodiments of the present invention relate generally to the use of non-pathogenic microorganisms to prevent the growth and/or activity of pathogenic microorganisms in food products. More specifically, several embodiments relate to manipulation of the pH of low acid foods by non-pathogenic microorganisms to generate a local environment that is adverse to pathogenic microorganisms.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: March 8, 2016
    Assignee: Starbucks Corporation
    Inventors: Lisa L. Beckman, Michael A. Bauman, Curtis R. Moon, Mark B. Satterfield, Marcia K. Walker, Dennis A. Lonergan
  • Patent number: 9278050
    Abstract: A dissolvable medication administration bag for the safe and effective crushing and administration of medication to patients who have difficulty swallowing pills. A dissolvable medication administration bag may be constructed in accordance with a pill crusher pouch embodiment into which a pill is placed prior to being crushed and subsequently the whole of pouch and the crushed pill contents are dissolved into a liquid, e.g. a beverage, as a means of reducing health hazards associated with current pill crushing practices such as inadvertent direct contact and aerosolization with subsequent inhalation of the crushed medication.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: March 8, 2016
    Inventor: Trevor Anderson
  • Patent number: 9271983
    Abstract: A composition including a plurality of active ingredients. A first active ingredient of the active ingredients is pyruvate. For each other active ingredient, an amount of that active ingredient is proportionally less than an amount of the first active ingredient. The composition can affect ATP and Krebs efficiency when ingested by an animal.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: March 1, 2016
    Assignee: BIOADATP, LLC
    Inventor: Kevin Meehan
  • Patent number: 9271942
    Abstract: A method of producing microcapsules of the type having a core and a coating encapsulating the core comprises the steps of providing a core-forming fluid stream and a coating-forming fluid stream, providing a two spray nozzle arrangement having a core nozzle disposed concentrically about a second nozzle, spraying the core-forming fluid stream from the core nozzle and the coat-forming fluid stream from the concentric nozzle to produce microcapsules, and solidifying the microcapsules upon formation in a suitable gas. Spray drying or spray chilling may be employed as the means of solidifying the microcapsules. Microcapsules having a core and a solid coat are also described.
    Type: Grant
    Filed: November 7, 2007
    Date of Patent: March 1, 2016
    Assignee: ROYAL COLLEGE OF SURGEONS IN IRELAND
    Inventor: Zebunnissa Ramtoola
  • Patent number: 9259430
    Abstract: The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.
    Type: Grant
    Filed: March 19, 2014
    Date of Patent: February 16, 2016
    Assignee: Metabolic Technologies, Inc.
    Inventors: John Rathmacher, John Fuller, Jr., Shawn Baier, Steve Nissen, Naji Abumrad
  • Patent number: 9238024
    Abstract: A method of improving health in a canine includes administering to the canine a nutritional supplement comprising an amino acid secretagogue composition, which stimulates the pituitary gland of the canines to produce growth hormone. The nutritional supplement may be administered orally. The nutritional supplement may comprise L-arginine hydrochloride, Oxo-proline, L-lysine hydrochloride, and cysteine. When desired, the nutritional supplement may consist essentially of L-arginine hydrochloride, Oxo-proline, L-lysine hydrochloride, N-acetyl-L-cysteine, L-glutamine, and schizonepeta powder.
    Type: Grant
    Filed: June 10, 2014
    Date of Patent: January 19, 2016
    Assignee: Quality IP Holdings, LLC
    Inventors: Amy L. Heaton, Mitchell K. Friedlander, Dennis Gay
  • Patent number: 9233090
    Abstract: The present invention relates to the field of nutrition; in particular to the prevention and/or treatment of malnutrition. One embodiment of the present invention relates to a nutritional composition enriched in cysteine for use in the treatment and/or prevention of malnutrition and disorders related thereto. Such a composition may in particular, but not exclusively, be useful for the elderly population.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: January 12, 2016
    Assignee: Nestec S.A.
    Inventors: Denis Breuille, Isabelle Papet, Karine Vidal
  • Patent number: 9226945
    Abstract: A nutritional composition comprising a partially hydrolyzed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-? per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: January 5, 2016
    Assignee: Nestec S.A.
    Inventors: Annick Mercenier, Marie-Claire Fichot, Adrian Zuercher
  • Patent number: 9216203
    Abstract: A natural antibiotic health supplement, having garlic, onion, horseradish root, cayenne or habanero peppers, ginger, organic unfiltered apple cider vinegar, unfiltered raw honey, cinnamon, echinacea, and monolaurin. The natural antibiotic health supplement is effective to support a person's immune system, and especially when it detects various common strains of viruses, bad bacteria, and infections.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: December 22, 2015
    Inventor: Franco Gennaro
  • Patent number: 9186356
    Abstract: Methods for rescuing learning, memory and/or motor function deficits associated with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) are disclosed. The method comprises: a) administering to an animal having FTLD-U a therapeutically effective amount of an autophagy inducer; b) causing a decrease in the amount of ubiquitinated TDP-43 aggregation forms in the brain of the animal; and c) causing an improvement of the learning, memory capacities and/or motor function of the animal.
    Type: Grant
    Filed: January 4, 2012
    Date of Patent: November 17, 2015
    Assignee: Academia Sinica
    Inventors: Che-Kun James Shen, Kuen-Jer Tsai
  • Patent number: 9179690
    Abstract: The present invention relates to edible products with masked bitter, sour and/or astringent taste. The new products comprise a sweetening agent and from 0.2 to 25% by weight plant sterol ester, wherein the amount of sweetening agent is reduced as compared to a regular product.
    Type: Grant
    Filed: April 22, 2004
    Date of Patent: November 10, 2015
    Assignee: RAISIO NUTRITION LTD.
    Inventors: Anniina Honkanen, Päivi Kuusisto, Ritva Lahtinen, Leena Koponen
  • Patent number: 9155704
    Abstract: The present invention relates to a more palatable pharmaceutical composition comprising carprofen and at least one flavoring agent, and more particularly pertains to a more palatable and more voluntarily consumed pharmaceutically active dosage of carprofen, made available in the form of an orally administered tablet that is easy to swallow, with the same dissolution profile and bioequivalence of less palatable carprofen compositions, such as those compositions without a flavoring agent, and used for the indication of relieving clinical symptoms of pain and inflammation associated with osteoarthritis and postoperative surgery in mammals, by reduced prostaglandin production via inhibition of cyclooxygenase-2. Also included are analytical methods for in vitro dissolution testing of this unique composition to demonstrate bioequivalence to less palatable non-flavored and chewable compositions.
    Type: Grant
    Filed: July 13, 2014
    Date of Patent: October 13, 2015
    Inventor: Jugal K. Taneja
  • Patent number: 9149061
    Abstract: The invention relates to a salt substitute mixture containing NaCl, KCl and sodium gluconate. The ratio by weight of KCl to sodium gluconate ranges from 1.5:1 to 1:1.5 and the proportion of NaCl is at least 45% by weight. Furthermore, the invention relates to the use of the mixture in the food industry and as a spice mixture.
    Type: Grant
    Filed: March 17, 2007
    Date of Patent: October 6, 2015
    Assignee: JUNGBUNZLAUER LADENBURG GMBH
    Inventors: Matthias Pfeiffer, Claudia Scholten, Sabine Oellers
  • Patent number: 9149050
    Abstract: Conjugated linoleic acid (CLA) or a derivative thereof may be used in reducing the rate of increase of fat mass in a growing child.
    Type: Grant
    Filed: April 14, 2010
    Date of Patent: October 6, 2015
    Assignee: STEPAN SPECIALTY PRODUCTS, LLC
    Inventors: Marianne O'Shea, Chryssanthi Stylianopoulos, Corey Edison Scott, Dale A. Schoeller
  • Patent number: 9145396
    Abstract: The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.
    Type: Grant
    Filed: November 7, 2013
    Date of Patent: September 29, 2015
    Assignee: Targacept, Inc.
    Inventors: Srinivasa Rao Akireddy, Balwinder Singh Bhatti, Timothy J. Cuthbertson, Gary Maurice Dull, Craig Harrison Miller, Joseph Pike Mitchener, Julio A. Munoz, Pieter Albert Otten
  • Patent number: 9144248
    Abstract: The use is described of a compound of Formula (I) As a flavoring or flavoring mixture for imparting, modifying and/or enhancing one, two or all the taste impressions umami, kokumi and salty. Flavoring mixtures, vegetable extracts and preparations according to the invention and associated uses and methods are also described.
    Type: Grant
    Filed: May 25, 2012
    Date of Patent: September 29, 2015
    Assignee: SYMRISE AG
    Inventors: Jakob Peter Ley, Katharina Reichelt, Susanne Paetz, Michael Backes, Katja Obst
  • Patent number: 9133176
    Abstract: Methods for the synthesis, isolation, and purification of procyanidin B2 are disclosed. The synthetic methods utilize epicatechin as a starting material and produce procyanidin B2 in high yields. The isolation methods extract procyanidin B2 from a sample of bark powder from plant matter of the genus Uncaria. The isolated and/or synthesized procyanidin B2 is used to treat amyloid disease, such as Alzheimer's disease and Parkinson's disease as well as improve cognitive performance and increase learning and memory in Alzheimer's patients. Pharmaceutical compositions containing the synthesized and/or isolated procyanidin B2 are also disclosed.
    Type: Grant
    Filed: May 12, 2008
    Date of Patent: September 15, 2015
    Assignee: PROTEOTECH INC.
    Inventors: Gerardo Castillo, Beth Nguyen, Paula Choi, Lesley Larsen, Stephen Lorimer, Alan Snow
  • Patent number: 9133255
    Abstract: Controlled studies demonstrate that products and related methods using soy related peptides lower total and LDL cholesterol levels in individuals. In one exemplary embodiment of the present disclosure, a product containing an effective amount of lunasin peptides that lowers cholesterol levels in an individual that consumes the lunasin peptides is provided. In another exemplary embodiment of the present disclosure, a composition containing an effective amount of lunasin peptides or lunasin peptide derivatives and one or more enzyme inhibitors is provided. In a related exemplary embodiment of the present disclosure, a method for lowering or reducing cholesterol levels in an individual is provided where a product containing an effective amount of lunasin peptides to an individual is provided and a claim that the product lowers or reduces cholesterol, total cholesterol, LDL cholesterol or lipid levels in an individual that consumes the composition is made.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: September 15, 2015
    Assignee: Soy Labs, LLC
    Inventor: Alfredo Flores Galvez